NYSE$USPH

US Physical Therapy Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Patient volumes remained robust and revenue increased by 15.6% compared to Q3 2020.

U.S. Physical Therapy reported strong Q3 2021 results with revenue up 15.6% year-over-year, driven by robust patient volumes. The company's net income attributable to USPH shareholders was $10.0 million, and adjusted EBITDA, excluding Relief Funds, was $19.9 million, a 1.8% increase compared to the same period last year.

  • Operating Results per diluted share, excluding Relief Funds, was $0.85, the same as in Q3 2020 and 21.4% higher than Q3 2019.
  • Adjusted EBITDA, excluding Relief Funds, was $19.9 million, 1.8% higher than Q3 2020 and 17.6% higher than Q3 2019.
  • Net patient revenue from physical therapy operations was $112.3 million, a 16.5% increase from Q3 2020.
  • Industrial injury prevention services revenue was $10.5 million, representing a 4.8% increase over Q3 2020.

Headline financials

Total Revenue

$124M

Previous: $109M+13.5%
EPS (adj)

$0.85

Previous: $0.86-1.2%
Net Rate per Visit

$102.93

No prior period
Free Cash Flow

$10M

Previous: $10.9M-8.3%
Net Income

$10M

Previous: $10.9M-8.3%
Operating Income

$16.9M

Previous: $19.9M-15.1%
Gross Profit

$29.8M

Previous: $30.4M-1.8%
Cash & Equivalents

$19.2M

Previous: $30.1M-36.3%
Total Assets

$630M

Previous: $575M+9.5%
Stock-Based Comp

$2.88M

Previous: $1.94M+48.5%

Revenue & EPS history

US Physical Therapy · Revenue · Quarterly

$124M

Q3 2021+13.5%vs Q3 2020
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

US Physical Therapy · $113M total across 1 segment · Q3 2021

  • Physical Therapy Operations
    $113M

Forward guidance

The company did not provide forward guidance in this earnings report.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-1.5%

Avg return

30 days after

53%

35 / 66 earnings

Positive

+17.3%

Q3 2024

Best reaction

-27.5%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+1.3%
Q4 2025-2.9%+1.9%-8.5%
Q3 2025+0.9%-15.8%-13.8%
Q2 2025+14.7%+20.4%+17.8%
Q1 2025-0.1%+8.8%+8.9%
Q4 2024-6.0%-9.5%-18.0%
Q3 2024+17.3%+14.8%+17.9%
Q2 2024-6.8%-3.9%-5.4%
Q1 2024-2.2%+0.2%-8.0%
Q4 2023+3.4%+2.8%+9.8%
Q3 2023-2.8%-3.3%+4.3%
Q2 2023-8.6%-8.1%-19.8%
Q1 2023+4.5%+10.1%+2.1%
Q4 2022+2.1%+2.2%-5.7%
Q3 2022-8.9%-4.0%-0.3%
Q2 2022-27.5%-29.9%-37.0%
Q1 2022-4.4%-4.1%+4.2%
Q4 2021-5.8%-6.5%-2.1%
Q3 2021-3.6%-8.2%-21.6%
Q2 2021-3.6%-5.4%-1.1%
Q1 2021+6.0%+4.5%+6.6%
Q4 2020-17.2%-19.8%-24.3%
Q3 2020+8.4%+26.6%+29.2%
Q2 2020+2.4%+1.1%+3.7%
Q1 2020-1.0%+2.7%+0.9%
Q4 2019-17.7%-16.0%-49.0%
Q3 2019-20.1%-20.4%-20.5%
Q2 2019+3.9%+6.1%+8.1%
Q1 2019+2.3%+3.3%-1.2%
Q4 2018+3.2%+3.4%+2.1%
Q3 2018+5.1%+6.5%+10.7%
Q2 2018+8.9%+7.0%+18.9%
Q1 2018-1.4%-0.5%+2.4%
Q4 2017+6.8%+2.7%+4.9%
Q3 2017-2.6%-2.9%+5.7%
Q2 2017+2.4%+2.6%-2.9%
Q1 2017-6.0%+0.8%-2.1%
Q4 2016+1.7%+2.0%-1.2%
Q3 2016-1.2%+0.5%+14.3%
Q2 2016+4.7%+4.0%+9.7%
Q1 2016+12.7%
Q4 2015+1.2%
Q3 2015+2.3%
Q2 2015-5.0%
Q1 2015+7.9%
Q4 2014+5.4%
Q3 2014-7.2%
Q2 2014+5.8%
Q1 2014+3.0%
Q4 2013-0.3%
Q3 2013-7.1%
Q2 2013+6.0%
Q1 2013+3.5%
Q4 2012-4.6%
Q3 2012+0.6%
Q2 2012+0.6%
Q1 2011+1.0%
Q1 2012+2.1%
Q4 2009-0.2%
Q4 2011-0.2%
Q3 2010+1.9%
Q3 2011+1.9%
Q2 2011-10.9%
Q4 2010-10.9%
Q2 2010-10.9%
Q1 2010+12.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro